A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patientsLeylah Drusbosky, Christopher R. Cogle, Madeleine Turcotte et al.|Blood Advances|2019Cited by 15
Heterogeneous Nuclear Ribonucleoprotein C is an Indispensable Target in Acute Myeloid LeukemiaVindhya Vijay, Christopher R. Cogle, Amy Meacham et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1